Rodriguez E, Lilenbaum RC. Small cell lung cancer: past, present, and future. Curr Oncol Rep. 2010;12(5):327–34.

Article  PubMed  Google Scholar 

Alexandrov LB, Ju YS, Haase K, et al. Mutational signatures associated with tobacco smoking in human cancer. Science. 2016;354(6312):618–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rudin CM, Poirier JT. Small-cell lung cancer in 2016: Shining light on novel targets and therapies. Nat Rev Clin Oncol. 2017;14(2):75–6.

Article  CAS  PubMed  Google Scholar 

Semenova EA, Nagel R, Berns A. Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev. 2015;29(14):1447–62.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):3.

Article  PubMed  PubMed Central  Google Scholar 

Wang Q, Gumus ZH, Colarossi C, et al. SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection. J Thorac Oncol. 2023;18(1):31–46.

Article  CAS  PubMed  Google Scholar 

Niu X, Chen L, Li Y, Hu Z, He F. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC. Semin Cancer Biol. 2022;86(Pt 3):273–85.

Article  CAS  PubMed  Google Scholar 

Petty WJ, Paz-Ares L. Emerging Strategies for the Treatment of Small Cell Lung Cancer: A Review. JAMA Oncol. 2023;9(3):419–29.

Article  PubMed  Google Scholar 

Horn L, Mansfield AS, Szczesna A, et al. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med. 2018;379(23):2220–9.

Article  CAS  PubMed  Google Scholar 

Liu SV, Reck M, Mansfield AS, et al. Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133). J Clin Oncol: off j Am Soc Clin Oncol. 2021;39(6):619–30.

Article  CAS  Google Scholar 

Schenk MW, Humphrey S, Hossain A, et al. Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer. Nat Commun. 2021;12(1):6652.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stewart CA, Gay CM, Xi Y, et al. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Nat Cancer. 2020;1:423–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thirusangu P, Ray U, Sarkar Bhattacharya S, et al. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma. Oncogene. 2022;41(33):4003–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Galluzzi L, Senovilla L, Vitale I, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31(15):1869–83.

Article  CAS  PubMed  Google Scholar 

Rebucci M, Michiels C. Molecular aspects of cancer cell resistance to chemotherapy. Biochem Pharmacol. 2013;85(9):1219–26.

Article  CAS  PubMed  Google Scholar 

Dexter DL, Leith JT. Tumor heterogeneity and drug resistance. J Clin Oncol: off J Am Soc Clin Oncol. 1986;4(2):244–57.

Article  CAS  Google Scholar 

Dentro SC, Leshchiner I, Haase K, et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell. 2021;1848:2239-54.e39.

Article  Google Scholar 

Stanzione M, Zhong J, Wong E, et al. Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer. Sci Adv. 2022;8(19):eabn1229

Lim JS, Ibaseta A, Fischer MM, et al. Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer. Nature. 2017;545(7654):360–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falco JP, Baylin SB, Lupu R, et al. v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line. J Clin Invest. 1990;85(6):1740–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mabry M, Nakagawa T, Nelkin BD, et al. v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer. Proc Natl Acad Sci USA. 1988;85(17):6523–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Calbo J, van Montfort E, Proost N, et al. A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. Cancer Cell. 2011;19(2):244–56.

Article  CAS  PubMed  Google Scholar 

Wu Q, Guo J, Liu Y, et al. YAP drives fate conversion and chemoresistance of small cell lung cancer. Sci Adv. 2021;7(40): eabg1850

Galli GG, Carrara M, Yuan WC, et al. YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers. Mol Cell. 2015;60(2):328–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moroishi T, Hansen CG, Guan KL. The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer. 2015;15(2):73–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374–403.

Article  PubMed  Google Scholar 

Cabanos HF, Hata AN. Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer. Cancers (Basel). 2021;13(11):2666.

Article  CAS  PubMed  Google Scholar 

Giraldo NA, Sanchez-Salas R, Peske JD, et al. The clinical role of the TME in solid cancer. Br J Cancer. 2019;120(1):45–53.

Article  PubMed  Google Scholar 

Chan JM, Quintanal-Villalonga A, Gao VR, et al. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell. 2021;39(11):1479-96.e18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu R, Shi P, Wang Z, Yuan C, Cui H. Molecular Mechanisms of MYCN Dysregulation in Cancers. Front Oncol. 2020;10:625332.

Article  PubMed  Google Scholar 

Grunblatt E, Wu N, Zhang H, et al. MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity. Genes Dev. 2020;34(17–18):1210–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 1996;84(3):345–57.

Article  CAS  PubMed  Google Scholar 

Jiang Y, Zhang H, Wang J, Liu Y, Luo T, Hua H. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol. 2022;15(1):34.

Article